Healthequity (HQY) Share-based Compensation (2013 - 2026)

Healthequity has reported Share-based Compensation for 14 years, with the latest figure at $22.2 million in Q3 2026.

• On a quarterly basis, Share-based Compensation rose 16.48% year-over-year to $22.2 million in Q3 2026; TTM through Jul 2026 was $81.3 million, a 6.61% increase from a year earlier, with the FY2026 full-year figure at $73.1 million, down 24.23% from the prior year.
• Share-based Compensation was $22.2 million for Q3 2026 at Healthequity, up from $19.4 million in the prior quarter.
• The five-year high for Share-based Compensation was $32.0 million in Q2 2024, with the low at $11.0 million in Q1 2022.
• Average Share-based Compensation over 5 years is $19.0 million, with a median of $19.1 million recorded in 2026.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation surged 75.9% in 2024, then plunged 55.23% in 2025.
• Over 5 years, Share-based Compensation stood at $18.2 million in 2022, then advanced by 19.22% to $21.7 million in 2023, then retreated by 2.49% to $21.1 million in 2024, then retreated by 2.75% to $20.5 million in 2025, then gained by 8.12% to $22.2 million in 2026.
• The last three Share-based Compensation figures came in at $22.2 million (Q3 2026), $19.4 million (Q2 2026), and $19.1 million (Q1 2026), per Business Quant data.